AgriCureX
AgriCureX develops precision antimicrobial platforms using bacteriophages, genomics, and AI to create targeted alternatives to antibiotics for livestock health. Its first product, SynBRD, targets Bovine Respiratory Disease pathogens in feedlot cattle with feed, spray/aerosol, and injectable formulations. The modular platform supports future disease-specific phage cocktails across cattle, aquaculture, dairy, equine, poultry, and companion-animal health.
- Biotechnology
- Drug Discovery & Therapeutics
- Agriculture Technology
- Artificial Intelligence
Funding
Founders
Founder details are not available yet.
Product
Problem
Bovine Respiratory Disease (BRD) accounts for the majority of sickness and deaths in cattle in modern feedlots, driving heavy antibiotic use and significant economic losses for producers. Rising global demand for animal protein, more intensive farming systems, and growing antimicrobial resistance on farms are compounding the problem, creating an urgent need for alternatives to conventional antibiotics.
Solution
AgriCureX provides a precision antimicrobial platform that combines bacteriophages, genomics, AI, and phage biobanking to develop targeted alternatives to antibiotics for livestock health. The company's first product, SynBRD, is a phage cocktail targeting BRD pathogens—including M. haemolytica, P. multocida, and H. somni—designed to reduce pathogen load, improve weight gain, and cut antibiotic use in feedlot cattle. Built as a modular platform, SynBRD is the first of many disease- and species-specific phage formulations in development across cattle, aquaculture, dairy, equine, poultry, and companion-animal health. The company integrates pathogen characterization, whole-genome sequencing, and advanced bioinformatics to support the research, development of targeted biologics and diagnostics for potential application in feedlot and dairy systems.
Target Audience
Primary customers are commercial livestock producers operating feedlots and dairy systems, as well as the broader agricultural industry seeking to reduce antibiotic use while maintaining productivity and animal welfare.
Features
- Modular phage platform enabling indication-specific formulations across cattle, aquaculture, dairy, equine, poultry, and companion-animal health
- SynBRD product pipeline targeting BRD pathogens M. haemolytica, P. multocida, and H. somni in feedlot-ready formats including feed, spray/aerosol, and injectable
- Genomics-enabled approach combining whole-genome sequencing and bioinformatics for pathogen characterization and targeted biologic development
- AI and data-driven biotechnology integration for detection of pathogen dynamics and informed livestock-health decision-making
- Foundational phage testing and feedlot-based R&D in progress, with additional pipeline programs in early development